๐‡๐ž๐ฅ๐ฉ ๐ฌ๐ก๐š๐ฉ๐ž ๐€๐ฎ๐ฌ๐ญ๐ซ๐š๐ฅ๐ข๐š๐ง-๐ฅ๐ž๐ ๐Œ๐‚๐€๐ƒ ๐ซ๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก
Studien / Umfragen

๐‡๐ž๐ฅ๐ฉ ๐ฌ๐ก๐š๐ฉ๐ž ๐€๐ฎ๐ฌ๐ญ๐ซ๐š๐ฅ๐ข๐š๐ง-๐ฅ๐ž๐ ๐Œ๐‚๐€๐ƒ ๐ซ๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก

๐‡๐ž๐ฅ๐ฉ ๐ฌ๐ก๐š๐ฉ๐ž ๐€๐ฎ๐ฌ๐ญ๐ซ๐š๐ฅ๐ข๐š๐ง-๐ฅ๐ž๐ ๐Œ๐‚๐€๐ƒ ๐ซ๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก
TAMS is proud to invite eligible community members to participate in a The University of Melbourne research project led by Master of Genomics and Health student Jackson Rees, with assistance from TAMS.
The project explores patient experiences of MCAD diagnosis and genetic testing, including KIT D816V and TPSAB1 testing, access to testing, how clearly results were explained and their role in clinical discussions.
๐‘ท๐’‚๐’“๐’•๐’Š๐’„๐’Š๐’‘๐’‚๐’•๐’Š๐’๐’ ๐’Š๐’ ๐’‘๐’“๐’๐’‹๐’†๐’„๐’•๐’” ๐’๐’Š๐’Œ๐’† ๐’•๐’‰๐’Š๐’” ๐’‰๐’†๐’๐’‘๐’” ๐‘ป๐‘จ๐‘ด๐‘บ ๐’‚๐’๐’… ๐’‡๐’–๐’•๐’–๐’“๐’† ๐’“๐’†๐’”๐’†๐’‚๐’“๐’„๐’‰๐’†๐’“๐’” ๐’…๐’†๐’Ž๐’๐’๐’”๐’•๐’“๐’‚๐’•๐’† ๐’•๐’‰๐’† ๐’๐’†๐’†๐’… ๐’‡๐’๐’“, ๐’‚๐’๐’… ๐’—๐’‚๐’๐’–๐’† ๐’๐’‡, ๐’“๐’†๐’”๐’†๐’‚๐’“๐’„๐’‰ ๐’„๐’๐’๐’…๐’–๐’„๐’•๐’†๐’… ๐’Š๐’ ๐‘จ๐’–๐’”๐’•๐’“๐’‚๐’๐’Š๐’‚. ๐‘พ๐’† ๐’†๐’๐’„๐’๐’–๐’“๐’‚๐’ˆ๐’† ๐’•๐’‰๐’๐’”๐’† ๐’˜๐’‰๐’ ๐’‚๐’“๐’† ๐’†๐’๐’Š๐’ˆ๐’Š๐’ƒ๐’๐’† ๐’•๐’ ๐’Ž๐’‚๐’Œ๐’† ๐’•๐’‰๐’†๐’Š๐’“ ๐’—๐’๐’Š๐’„๐’†๐’” ๐’‰๐’†๐’‚๐’“๐’….

๐˜—๐˜ญ๐˜ฆ๐˜ข๐˜ด๐˜ฆ ๐˜ณ๐˜ฆ๐˜ข๐˜ฅ ๐˜‘๐˜ข๐˜ค๐˜ฌ๐˜ด๐˜ฐ๐˜ฏโ€™๐˜ด ๐˜ณ๐˜ฆ๐˜ค๐˜ณ๐˜ถ๐˜ช๐˜ต๐˜ฎ๐˜ฆ๐˜ฏ๐˜ต ๐˜ฆ๐˜ฎ๐˜ข๐˜ช๐˜ญ below ๐˜ค๐˜ข๐˜ณ๐˜ฆ๐˜ง๐˜ถ๐˜ญ๐˜ญ๐˜บ ๐˜ฃ๐˜ฆ๐˜ง๐˜ฐ๐˜ณ๐˜ฆ ๐˜ฅ๐˜ฆ๐˜ค๐˜ช๐˜ฅ๐˜ช๐˜ฏ๐˜จ ๐˜ธ๐˜ฉ๐˜ฆ๐˜ต๐˜ฉ๐˜ฆ๐˜ณ ๐˜ต๐˜ฐ ๐˜ฑ๐˜ข๐˜ณ๐˜ต๐˜ช๐˜ค๐˜ช๐˜ฑ๐˜ข๐˜ต๐˜ฆ.

Dear TAMS community,
This email is being sent to invite you to participate in the research study survey for the project โ€˜Genomic Testing for Clonal Mast Cell Activation Disorders: Access, Experience and Current Practiceโ€™. We are contacting individuals within the mast cell activation disorder (MCAD), also known as mast cell disease (MCD), community in hopes of recruiting people who have received a positive diagnosis of mast cell activation syndrome (MCAS) or mastocytosis. To participate we require you to be over the age of 18.
This study aims to highlight genetic testing in the landscape of MCADs, more specifically, within MCAS or mastocytosis. This includes the utility, accuracy, and prominence of genetic testing currently within the diagnostic process.
The survey has 3 sections and will take roughly 10 minutes to complete. The survey will include questions regarding personal medical history, including diagnosis and testing. Surveys will be anonymous.
To complete the survey or read further information, please click the link below. This will take you to the survey consent and participant information page. For further questions or concerns, do not reply to this email; please use one of the contacts provided on the information page.
Regards,
Jackson Rees, BSc
Master of Genomics and Health
University of Melbourne

Back to overview